Medicare Enrolled

Dr. Richmond Roeske, M.D.

Ophthalmology · Upland, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
555 N 13TH AVE, Upland, CA 91786
9099828846
In practice since 2006 (19 years)
NPI: 1720009913 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Roeske from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roeske? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Roeske

Dr. Richmond Roeske is an ophthalmology specialist in Upland, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Roeske performed 2,807 Medicare services across 2,161 unique beneficiaries.

Between the years covered by Open Payments, Dr. Roeske received a total of $20,057 from 34 pharmaceutical and/or device companies across 346 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Roeske is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 35% volume in CA $20,057 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,807
Medicare services
Top 35% in CA for ophthalmology
2,161
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~148 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
619 $70 $120
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
456 $92 $140
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
387 $166 $599
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
198 $103 $209
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
197 $32 $165
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
182 $434 $3,570
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
182 $50 $150
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
182 $33 $360
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
147 $27 $165
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
88 $280 $1,529
New patient eye exam, problem focused
A focused examination of the visual system performed during a new patient visit.
42 $53 $129
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
25 $27 $70
Dilation of eye fluid drainage
A procedure to widen the drainage pathways in the eye to help fluid flow out more easily.
22 $303 $3,230
Cataract removal with artificial lens and drainage device insertion
Surgical removal of the eye's natural lens followed by the insertion of an artificial lens and a drainage device into the front chamber of the eye.
21 $537 $7,854
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
20 $13 $187
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
17 $22 $76
Removal of foreign body or stone from tear passages
A procedure to remove a foreign object or stone from the tear ducts. This clears blockages in the passages that drain tears from the eye.
11 $466 $1,794
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $114 $204
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.5% high complexity
13.1% medium
80.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$20,057
Total received (2018-2024)
Avg $2,865/year across 7 years
Top 10% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
346
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,320 (96.3%)
Scientific / Research
Research funding and grants
$387 (1.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$350 (1.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,211
2023
$2,096
2022
$1,950
2021
$4,344
2020
$1,494
2019
$2,967
2018
$2,994

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$1,225
Sight Sciences, Inc.
$779
RxSight Inc
$510
ABBVIE INC.
$387
Glaukos Corporation
$350
BIOTISSUE HOLDINGS INC.
$301
Johnson & Johnson Surgical Vision, Inc.
$295
Amgen Inc.
$232
Bausch & Lomb Americas Inc.
$94
Tarsus Pharmaceuticals, Inc.
$36
Top 3 companies account for 59.7% of 2024 payments
All-time payments by company (2018-2024) ›
Alcon Vision LLC
$10,571
Alcon Laboratories Inc
$2,214
Sight Sciences, Inc.
$1,663
RxSight Inc
$661
Johnson & Johnson Surgical Vision, Inc.
$568
Shire North American Group Inc
$508
Glaukos Corporation
$458
ABBVIE INC.
$449
BIOTISSUE HOLDINGS INC.
$301
Ivantis, Inc
$273
Novartis Pharmaceuticals Corporation
$268
TissueTech, Inc.
$242
AbbVie Inc.
$239
Amgen Inc.
$232
Bausch & Lomb Americas Inc.
$219
Aerie Pharmaceuticals, Inc.
$200
Beaver-Visitec International, Inc.
$160
Alcon Research Ltd
$158
Allergan, Inc.
$125
Kala Pharmaceuticals, Inc.
$61
Ocular Therapeutix, Inc.
$61
Bausch & Lomb, a division of Bausch Health US, LLC
$44
Horizon Therapeutics plc
$42
Oyster Point Pharma, Inc.
$42
Eyevance Pharmaceuticals LLC
$41
EYEVANCE PHARMACEUTICALS LLC
$41
Carl Zeiss Meditec, Inc.
$39
Tarsus Pharmaceuticals, Inc.
$36
Allergan Inc.
$34
Dompe US, Inc.
$31
Sun Pharmaceutical Industries Inc.
$22
Carl Zeiss Meditec USA, Inc.
$19
GlaxoSmithKline, LLC.
$18
Optos, Inc.
$15
Top 3 companies account for 72.0% of all-time payments
Associated products mentioned in payments ›
ALPHAGAN P · AMO PHACO NEEDLE · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · BEXSERO · BROMSITE · COMBIGAN · Centurion · Clareon · CyPass · DEXTENZA · DURYSTA · ENVISTA ENVY · FORUM · Flarex · HYDRUS Microstent · Hydrus · IC-8 Apthera IOL · INVELTYS · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE) · LUMIGAN · LenSx · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · ORA · OXERVATE · PANORAMIC OPHTHALMOSCOPE · PanOptix · Photrexa · Prokera · QUATERA 700 · RXSIGHT CONTACT LENS · ReSTOR · Rocklatan · SYMPHONY · TEARCARE SYSTEM · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare SmartLid · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · TobraDex ST · Tobradex ST · VUITY · VYZULTA · Wavelight Refractive Suite · XDEMVY · XIIDRA · enVista MX60 IOL · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for ophthalmology in CA.

Looking for an ophthalmology specialist in Upland?
Compare ophthalmologists in the Upland area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
261
Per 100K population
11.9
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Roeske is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 10% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Roeske experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Roeske performed 619 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Roeske receive payments from pharmaceutical companies?
Yes. Dr. Roeske received a total of $20,057 from 34 companies across 346 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roeske's costs compare to other ophthalmologists in Upland?
Dr. Roeske's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roeske) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →